| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |